Evidence shows supervised exercise programs significantly improve function and quality of life in patients with axial ...

For author information and disclosures, see end of text. Axial spondyloarthritis (axSpA) is a chronic, immune-mediated, inflammatory condition consisting of 2 subsets that have been clinically defined ...

Please provide your email address to receive an email when new articles are posted on . Etoricoxib may be a potential therapy for patients with axial ankylosing spondylitis who do not respond well to ...

Please provide your email address to receive an email when new articles are posted on . Patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis share comparable disease burden ...

Atul A. Deodhar, MD: The prevalence of axial spondyloarthritis was recently studied in the United States. In the NHANES study, which is the National Health and Nutritional Examination Survey study ...

Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that affects the spinal joints and the joints that connect the bottom of the spine to the hip bones (the sacroiliac joints). Experts ...

An updated guideline by two British medical societies is expected to expand access to biologics for patients with axial spondyloarthritis (axSpA; including ankylosing spondylitis [AS]) and increase ...

—Researchers in Canada compared isolated axial psoriatic arthritis, axial PsA with peripheral involvement, and isolated axial ankylosing spondylitis with psoriasis, to determine which factors predict ...

For patients with axial spondyloarthritis (axSpA) who do not benefit from or cannot take nonsteroidal anti-inflammatory drugs (NSAIDs), new treatment options include agents in multiple drug classes.

Ankylosing spondylitis can be a devastating disease. But the good news is that the future is brighter than ever before. Here’s why I’m so optimistic. Doctors -- including primary care physicians -- ...